Poor prognostic factors for relapse of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies after combination therapy
The presence of A/S-ILD, higher serum ALD and SP-D levels, and lower %FVC are useful indicators for predicting anti-ARS-ILD relapse.
Authors
- Takeshi Shoda (ORCID: https://orcid.org/0000-0001-5041-8091)
- Katsumasa Oe
- Yumiko Wada
- Shogo Matsuda (ORCID: https://orcid.org/0000-0003-0023-3616)
- Tohru Takeuchi (ORCID: https://orcid.org/0000-0002-0065-929X)
- Takao Kiboshi
- Ayana Okazaki
- Takayasu Suzuka
- Takuya Kotani (ORCID: https://orcid.org/0000-0003-2190-0780)
Institutions
- Osaka University of Pharmaceutical Sciences (JP)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3389/fimmu.2024.1407633
- Citations
- 2
- Primary Topic
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Type
- article
- Field-Weighted Citation Impact
- 0.84